How Hong Kong became a leading hub for biotech growth

[Paid Post: @HKEX Group]
Investments in biotechnology have been rapidly gaining momentum in Hong Kong, particularly as the Covid-19 pandemic draws attention to new innovations in health care. In just three years, the city has become Asia’s largest biotech fundraising hub and the second-largest globally, thanks to listing reforms implemented by HKEX and proximity to the world’s second-largest health care industry in mainland China . Nicolas Aguzin, chief executive officer of HKEX, and Li Bin, founder and chief investment officer of health care-focused asset management firm Lake Bleu Capital, explain more about the factors behind Hong Kong’s vital role in the biotech growth story.

#Ad #HKEX #BiotechSummit #Biotech #HongKong

Follow us on:

[Winninghan]

Nothing here on the local biotech talent, promising sub-sectors where HK may enjoy particular comparative advantages, specific research achievements or product innovation .... only talking head exit strategists and people looking to cash in on others' lifelong work in the field. I have nothing against them -- they have their role to play -- but this is just a plug for the HKEX.

[สมมติไม่มีตัวตน]

เกาะฮ่องกง ศูนย์รวมระบบทุนระดับโลก ในทุกๆวงการจริงๆ เกาะที่ทรงอิทธิพล ติดอันดับโลก

[Compassionless]

*ahem* used to be, HK no longer the same HK that got it to that point in the first place. RIP